Globus Medial completed its acquisition of Nevero, a spinal cord stimulator company, according to an April 3 news release.

Globus Medical has completed its acquisition of the US-based medical device company Nevro, broadening its market presence in ...

Globus Medical (NYSE:GMED) announced today that that it completed its previously announced acquisition of Nevro.

Spinal cord stimulators have grown in popularity over the past several years as patients see benefits in the less-invasive ...

Nevro Corp. engages in the development of ... It develops and commercializes the senza spinal cord stimulation system, an evidence-based neuromodulation platform for the treatment of chronic ...

A 24-month study compared CMM alone versus Nevro’s high-frequency (10 kHz) spinal cord stimulation (SCS) system for treating NSRBP. In April 2024, Medtronic plc, a world leader in medical technology, ...

The acquisition of Nevro further expands Globus Medical's presence in the musculoskeletal market, unlocking a $2.5 billion market opportunity. This strategic move positions Globus to further add to ...

Nevro NVRO is well-poised for growth in ... However, concerns regarding softness in the spinal cord stimulation (SCS) market and dependence on third-party payers persist. This Zacks Rank #2 ...